Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGLN1 | Q9GZT9 | 2/20 | 0.37 |
| ▸ | FASN | P49327 | 9/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.34 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.33 |
| ▸ | KDM4A | O75164 | 1/20 | 0.33 |
| ▸ | ABL1 | P00519 | 1/20 | 0.33 |
| ▸ | RIN1 | Q13671 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | MELK | Q14680 | 2/20 | 0.32 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.32 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8948982 | 0.85 | EGLN1 (0.38) | EGLN1FASNHPGDROCK2GABRA5 | |
| SCHEMBL8949363 | 0.83 | TMPRSS15 (0.43) | EGLN1FASNHPGDGABRA5POLB | |
| SCHEMBL8949356 | 0.83 | TMPRSS15 (0.43) | EGLN1FASNHPGDGABRA5POLB | |
| SCHEMBL8885599 | 0.74 | FASN (0.43) | FASNROCK2KDM4AABL1RIN1 | |
| SCHEMBL8948981 | 0.72 | GPR119 (0.38) | EGLN1FASNHPGDROCK2GABRA5 | |
| SCHEMBL8948974 | 0.72 | GPR119 (0.38) | EGLN1FASNHPGDROCK2GABRA5 | |
| SCHEMBL8949176 | 0.72 | POLB (0.36) | EGLN1FASNHPGDGABRA5POLB | |
| SCHEMBL8949178 | 0.72 | POLB (0.36) | EGLN1FASNHPGDGABRA5POLB | |
| SCHEMBL8949414 | 0.71 | ITGB3 (0.39) | EGLN1FASNGABRA5POLB | |
| SCHEMBL8949416 | 0.71 | ITGB3 (0.39) | EGLN1FASNGABRA5POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5563268-A | FOR PREVENTING CELL AGGLOMERATION, TREATING THROMBOSIS, ARTERIOSCLEROSIS, BRAIN, LUNG OR CARDIOVASCULAR DISORDERS | DR. KARL THOMAE GMBH (DE) | 1996-10-08 | — | — | US | disclosed |
| US-5418233-A | FOR INHIBITING CELL AGGREGATION | KARL THOMAE GMBH (DE) | 1995-05-23 | — | — | US | disclosed |
| EP-0537696-A1 | Heterobiaryl derivatives, medicines containing those compounds and process for their preparation | Dr. Karl Thomae GmbH (DE) | 1993-04-21 | — | — | EP | disclosed |